Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells

Cancer Research

Volumn 59, Issue 12, 1999, Pages 2829-2833

  Sun, Shi Yong ^a,d   Yue, Ping ^a   Wu, Gen Sheng ^b   El Deiry, Wafik S ^b   Shroot, Braham ^c   Hong, Waun K ^a   Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Galderma R and D   (France)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RETINOID;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL GROWTH; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; WART VIRUS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CASPASES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYTOCHROME C GROUP; CYTOPLASM; DNA FRAGMENTATION; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; ONCOGENE PROTEINS, VIRAL; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; REPRESSOR PROTEINS; RETINOIDS; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033564118     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Greenblant, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clue to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4879, 1994.
2. Bates, S., and Vousden, K. H. p53 in signalling checkpoint arrest and apoptosis. Curr. Opin. Genet. Dev., 6: 1-7, 1996.
3. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80: 293-299, 1995.
4. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
5. Wu, G. S., Burns, T. F., McDonald, E. R., III, Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D-D., Zhou, J-Y., Muschel, R., Hamilton, S. R., Spinner, N. B., Markowitz, S., Wu, G., and El-Deiry, W. S. Killer/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet., 17: 141-143, 1997.
6. DeLuca, L. M. Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J., 5: 2924-2933, 1991.
7. Chambon, P. The retinoid signaling pathway: molecular and genetic analysis. Semin. Cell Biol., 5: 115-125, 1994.
8. Lotan, R. Retinoid and apoptosis: implication for cancer chemoprevention and therapy. J. Natl. Cancer Inst., 87: 1655-1657, 1995.
9. Sun, S-Y., Yue, P., Shroot, B., Michel, S., Mawson, M. I., Lamph, W. W., Heyman, R. A., Teng, M., Chandraratna, R. A. S., Shudo, K., Hong, W. K., and Lotan, R. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res., 57: 4931-4939, 1997.
10. Sun, S-Y., Yue, P., Shroot, B., Hong W. K., and Lotan, R. Induction of apoptosis in human non-small cell lung carcinoma cells by a novel synthetic retinoid CD437. J. Cell. Physiol., 173: 279-284, 1997.
11. Shao, Z-M., Dawson, M. I., Li, X. S., Rishi, A. K., Sheiki, M. S., Han, Q-X., Ordonez, J. V., Shoot, B., and Fontana, J. A. p53 independent G0-G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene, 11: 493-504, 1995.
12. Schadendorf, D., Kern, M. A., Artuc, M., Pahl, H. L., Rosenbach, T., Fichtner, I., Nurnberg, W., Stuting, S., Stebut, E. V., Worm, M., Makki, A., Jurgovsky, K., Kolde, G., and Henz, B. M. Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J. Cell Biol., 135: 1889-1898, 1996.
13. Oridate, N., Higuchi, M., Suzuki, S., Shroot, B., Hong, W. K., and Lotan, R. Rapid induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 6[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437). Int. J. Cancer, 70: 484-487, 1997.
14. Hsu, C. A., Rishi, A. K., Li, X-S., Gerald, T. M., Dawson, M. I., Schiffer, C., Reichert, U., Shroot, B., Poirer, G. C., and Fontana, J. A. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood, 89: 4470-4479, 1997.
15. Adachi, H., Preston, G., Harvat, B., Dawson, M. I., and Jetten, A. Inhibition of cell proliferation and induction of apoptosis by the retinoid AHPN in human lung carcinoma cells. Am. J. Respir. Cell Mol., 18: 823-333, 1998.
16. Li, Y., Lin, B., Agadir, A., Liu, R., Dawson, M. I., Reed, J. C., Fontana, J. A., Bost, F., Hobbs, P. D., Zheng, Y., Chen, G-Q., Shroot, B., Mercola, D., and Zhang, X-K. Molecular determination of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines. Mol. Cell. Biol., 18: 4719-4731, 1998.
17. Bernard, B. A., Bernardon, J-M., Delescluse, C., Martin, B., Lenoir, M-C., Margnan, J., Charpentier, B., Pilgrim, W. R., Reichert, U., and Shroot, B. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ. Biochem. Biophys. Res. Commun., 186: 977-983, 1992.
18. Sun, S-Y., Yue, P., Wu, G. S., El-Deiry, W. S., Shroot, B., Hong, W. K., and Lotan, R. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells. Oncogene, 18: 2357-2365, 1999.
19. Mitsudomi, T., Steinberg, S. M., Nau, M. M., Carbone, D., D'Amico, D., Bodner, S., Oie, H. K., Linnoila, I., Mulshine, J. L., Minna, J. D., and Gazdar, A. F. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene, 7: 171-180, 1992.
20. Wu, G. S., and El-Deiry, W. S. Apoptosis death of tumor cells correlates with chemosensitivity independent of p53 and Bcl-2. Clin. Cancer Res., 2. 623-633, 1996.
21. Bossy-Wetzel, E., Newmeyer, D. D., Green, D. R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J., 17: 37-49, 1998.
22. Oridate, N., Lotan, D., Xu, X. C., Hong W. K., and Lotan, R. Differentiation of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res., 2: 855-863, 1996.
23. Patel, T., Gores, G. J., and Kaufmann, S. H. The role of proteases during apoptosis. FASEB J., 10: 587-597, 1996.
24. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. Induction of apoptotic program in cell-free extract for dATP and cytochrome c. Cell. 86: 147-157, 1996.
25. Liu, X., Zou, H., Slaughter, C., and Wang, X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89: 175-184, 1997.
26. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136, 1990.
27. Zou, H., Henzel, W. J., Liu, X., Lutschg, A., and Wang, X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell, 90: 405-413, 1997.
28. Sabbatini, P., Lin, J., Levine, A. J., and While, E. Essential role for p53-mediated transcription in E1A-induced apoptosis. Gene Dev., 9: 2184-2192, 1995.
29. Polyak, K., Xia, Y., Zzweier, J. L., Kinzler, K. W., and Vogelstein, B. A model for p53-induced apoptosis. Nature (Lond.), 389: 300-305, 1997.
30. Knudson, C. M., Tung, K. S. K., Tourtellotte, W. G., Brown, G. A. J., and Korsmeyer, S. J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science (Washington DC), 270: 96-99, 1995.